ProfileGDS5822 / ILMN_2456946
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 96% 97% 97% 97% 96% 97% 97% 98% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11434.496
GSM1276600PDAC Late Ablation Control 22139.297
GSM1276601PDAC Late Ablation Control 32155.297
GSM1276602PDAC Late Ablation 11775.797
GSM1276603PDAC Late Ablation 21538.796
GSM1276604PDAC Late Ablation 32399.597
GSM1303940PDAC Late Ablation_anti-CTLA4 1198997
GSM1303941PDAC Late Ablation_anti-CTLA4 22785.598
GSM1303942PDAC Late Ablation_anti-CTLA4 31623.796